Plant Science

BioConsortia Latest News: Secures $15M In Latest Funding Round

BioConsortia's development of nitrogen-fixing products shows promising field trial results in row crops, offering a sustainable alternative.

Key Takeaways:

  • BioConsortia, Inc., announces the closure of an internal financing round led by Otter Capital, aimed at developing microbial solutions for agriculture.
  • The funding will facilitate the expansion of field trials globally and enhance microbial gene-editing research.
  • CEO Marcus Meadows-Smith emphasizes the effectiveness of their nitrogen-fixing seed treatments, validated through extensive field trials.
  • The investment will also support the expansion of their Davis, CA lab and improvements in fermentation and formulation capabilities, anticipating product commercialization in 2024.

Funding Aimed at Enhancing Crop Yields and Pest Control

BioConsortia, Inc., a leading company in the field of agricultural technology, has successfully completed an internal financing round to further the development of microbial products. These products are designed to enhance crop yields through mechanisms such as nitrogen fixation and to provide environmentally friendly control of nematodes, fungi, and soil insects. Led by Otter Capital, this financing round is a reflection of confidence in BioConsortia’s recent field trials and advances in microbial gene-editing technology.

Endorsement of Nitrogen-Fixation Technologies

Marcus Meadows-Smith, CEO of BioConsortia, highlighted the success and potential of their technologies, stating, “We have validated the consistency and impact of our nitrogen-fixing seed treatments through hundreds of field trials across a wide array of crops in recent years. This announced investment underlines our confidence that these technologies, with their extended shelf- and on-seed life, set a new standard for nitrogen-fixation products.”

This statement reflects the company’s belief in their product’s ability to revolutionize nitrogen fixation in agriculture, indicating a move towards more sustainable farming practices.

Expansion Plans and Intellectual Property

The funds from this round will be allocated towards expanding field trial programs in significant agricultural regions around the world, enhancing the company’s research in microbial gene-editing. BioConsortia aims to strengthen its intellectual property estate, securing its leadership position in the sector.

Infrastructure Development for Future Growth

A portion of the investment will be used to expand BioConsortia’s laboratory facilities in Davis, California. This expansion is essential for accommodating the growing team focused on microbial gene-editing and for upgrading fermentation and formulation capabilities. Meadows-Smith expressed optimism about the future, noting that “the Company’s biofungicide, bionematicide, postharvest decay control and nitrogen-fixing products approach commercialization beginning in 2024.”


BioConsortia Recent News

Discover the company in our directory here.

Advances Nitrogen-Fixing Products, Demonstrating Significant Field Trial Success in 2023 (2024/01/21)

BioConsortia has developed nitrogen-fixing products for row crops that can replace nitrogen fertilizers and increase crop yields. The effectiveness of these products was validated in extensive field trials in 2023. The company’s proprietary microbes can remain active in the root zone throughout the growing season, ensuring a continuous supply of nitrogen to the crops. BioConsortia’s nitrogen-fixing seed products remain stable for more than two years, extending their application to in-season side-dress or in-furrow uses. The company is participating in upcoming industry events to showcase its technology and engage with stakeholders.

Develops Nitrogen-Fixing Products (2024/01/29)

BioConsortia, Inc. has developed groundbreaking nitrogen-fixing products that expand the market potential to include new crop opportunities. The 2023 field trial results have been a milestone, demonstrating that their products can effectively replace nitrogen levels in various crops. These products reduce the dependency on synthetic nitrogen fertilizers and enable growers to balance crop productivity with ecological safety more effectively. BioConsortia’s development of nitrogen-fixing products represents a significant advancement in sustainable agriculture, setting a new standard for balancing agricultural productivity with ecological safety.

BioConsortia Expands into Brazil (2023/09/20)

BioConsortia, Inc. has expanded into Brazil, with a significant biological product market valued at over $850 million. This strategic move focuses on introducing advanced microbial products that reduce reliance on synthetic nitrogen fertilizers and provide robust crop protection. The company’s products, which have a long shelf-life and are as effective as chemical alternatives, align with Brazil’s growing adoption of biological products, especially in broadacre crops. With the appointment of Cesar Lamonega and Debora Chaves Coelho Leite to spearhead business development and regulatory affairs and a partnership with Mosaic Company, BioConsortia is poised to enhance its commercial activities in Brazil. This expansion is part of BioConsortia’s broader goal to improve farmer profitability and reduce the ecological impact of agriculture globally, with ongoing field tests in Brazilian corn production to showcase the benefits of their innovative products.

Expands Field Trials & Closes Financing Round (2023/04/19)

BioConsortia, a biotech firm, is conducting an extensive field trials program for its agricultural microbial solutions. The program aims to demonstrate the company’s pipeline, which features solutions for nematodes, nitrogen use, and food waste. The trials will take place in Asia, Latin America, Europe, and North America. BioConsortia relies on commercial partners to bring its products to market. The company closed a financing round and plans to use the funds to expand globally and advance its pipeline.

Image provided by BioConsortia

administrator
As a dedicated journalist and entrepreneur, I helm iGrow News, a pioneering media platform focused on the evolving landscape of Agriculture Technology. With a deep-seated passion for uncovering the latest developments and trends within the agtech sector, my mission is to deliver insightful, unbiased news and analysis. Through iGrow News, I aim to empower industry professionals, enthusiasts, and the broader public with knowledge and understanding of technological advancements that shape modern agriculture. You can follow me on LinkedIn & Twitter.

1 Comment

  • […] infusion of new funds will propel PhageLab’s expansion into Brazil, its primary market, and help the company make inroads into the US. Additionally, the funding will […]

Leave a Reply

X